José A. Fontenla

Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents

C. FERNANDEZ, Ofelia Nieto, Emilia Rivas et al. · Carbohydrate Research · 2000 · 73 citations

Medicinal Chemistry, Glycosyl Dopamine Derivatives, Biochemistry +12

Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1Electronic supplementary information (ESI) available: experimental details for the preparation of all derivatives and biological assays. See http://www.rsc.org/suppdata/ob/b2/b212066f/

C. FERNANDEZ, Ofelia Nieto, José A. Fontenla et al. · Organic & Biomolecular Chemistry · 2003 · 71 citations

Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study

María João Matos, Santiago Vilar, Rosa Ma Gonzalez-Franco et al. · European Journal of Medicinal Chemistry · 2013 · 60 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +10

Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy

Fernanda Rodríguez‐Enríquez, María Carmen Costas-Lago, Pedro Besada et al. · Bioorganic Chemistry · 2020 · 51 citations · Full text

Molecular Pharmacology, Medicine, Psychotropic Medication +7

Neuropharmacological effects of the ethanolic extract of Sida acuta

Dora Benjumea, Isabel Gómez-Betancur, Julieta Vásquez et al. · Revista Brasileira de Farmacognosia · 2016 · 35 citations · Full text